What is the ticker symbol for Cognition Therapeutics?

Cognition Therapeutics trades under the ticker CGTX on NASDAQ.

What sector does Cognition Therapeutics operate in?

Cognition Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze CGTX in a portfolio?

PortView shows CGTX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Cognition Therapeutics (CGTX) Stock Analysis

NASDAQHealthcareBiotechnology

$1.02+0.99%

1-year price historyRange $0.59 – $2.61

52-week range$1.02

$0.55$2.67

What Cognition Therapeutics does

Cognition Therapeutics, Inc. is a biopharmaceutical company in the clinical stage, focused on identifying and advancing small molecule treatments. The firm's research and development efforts are primarily directed towards age-related neurodegenerative conditions affecting the central nervous system, as well as retinal disorders. Its most advanced experimental therapy is CT1812, which acts as a sigma-2 receptor antagonist. This compound is currently being evaluated in Phase II clinical trials for the management of mild-to-moderate Alzheimer's disease and dementia with Lewy bodies (DLB). Additionally, it has successfully concluded Phase I trials for early-stage Alzheimer's and is undergoing preclinical investigation for dry age-related macular degeneration (AMD). The company's pipeline also includes CT2168, a treatment candidate for synucleinopathies—a category of diseases encompassing DLB and Parkinson's disease—and CT2074, which is in development for dry AMD. Cognition Therapeutics, Inc. was established in 2007 and operates from its headquarters in Purchase, New York.

Key metrics

Market cap

$91.29M

P/E (TTM)

-4.25

EPS (TTM)

$-0.24

Beta

1.78

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$1.03

200-day avg

$1.20

52-week high

$2.67

52-week low

$0.55

CEO

Lisa Ricciardi

ETFs linked to CGTX

Broad-market and Healthcare sector ETFs an investor holding Cognition Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how CGTX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze CGTX in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Cognition Therapeutics?: Cognition Therapeutics trades under the ticker CGTX on NASDAQ.
Which exchange is CGTX listed on?: CGTX is listed on NASDAQ.
What sector does Cognition Therapeutics operate in?: Cognition Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze CGTX in a portfolio?: PortView shows CGTX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.